Position in NBIX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$30,761,290
+$410,805 QoQ
Shares Held
233,500
+9.1% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Sep 30, 2020CallValue
$0
CallShares
0
PutValue
$9,616
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $498,843,244 across 54 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,049,626 | $124,076,289 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
3,183,971 | $44,097,998 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
62,008 | $36,769,503 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
647,731 | $31,188,247 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
233,500 | $30,761,290 | |
| 6 | VTRS |
Viatris Inc
|
2,095,093 | $28,304,706 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,111,137 | $26,589,508 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
877,568 | $26,432,348 |
All Filings in NBIX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,761,290 | 233,500 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $30,350,485 | 213,992 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $14,174,870 | 100,975 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,351,912 | 114,185 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,235,979 | 237,215 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $39,563,160 | 289,840 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $61,449,591 | 533,324 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $59,281,941 | 430,609 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $59,578,957 | 431,982 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $40,533,328 | 307,630 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $31,245,862 | 277,741 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,791,358 | 220,481 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $24,463,052 | 241,682 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $23,713,498 | 198,539 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,813,566 | 130,059 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $6,421,982 | 65,880 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,746,187 | 50,626 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $26,482,930 | 310,942 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $27,865,307 | 290,536 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $28,414,715 | 291,972 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $13,497,911 | 138,796 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $5,427,410 | 56,624 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $9,616 | 100 | Put | Defined | 2020-10-30 | |
| 2020-09-30 | $3,419,161 | 35,557 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $7,500,560 | 61,480 | Shares | Defined | 2020-08-06 | |
| 2020-06-30 | $18,300 | 150 | Put | Defined | 2020-08-06 | |
| 2020-03-31 | $40,245 | 465 | Put | Defined | 2020-05-13 | |
| 2020-03-31 | $3,960,960 | 45,765 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||